Research progress on immunotherapy-acquired drug resistance in non-small cell carcinoma.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 437, doi. 10.3872/j.issn.1007-385x.2025.04.014
- Publication type:
- Article
Works matching IS 1007385X AND DT 2025 AND VI 32 AND IP 4
Results: 15
1
2
The role of protein palmitoylation in tumorigenesis, progression, and treatment.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 425, doi. 10.3872/j.issn.1007-385x.2025.04.012
- Publication type:
- Article
3
The dual role of cell senescence in tumor therapy and its clinical significance.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 432, doi. 10.3872/j.issn.1007-385x.2025.04.013
- Publication type:
- Article
4
The expression of circular RNA hsa_circ_0046701 in glioma tissues and its effect on the proliferation, migration and invasion of glioma U251 cells.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 386, doi. 10.3872/j.issn.1007-385x.2025.04.006
- By:
- Publication type:
- Article
5
Exploration of radiotherapy as a combined treatment modality with in situ vaccines in the treatment of advanced soft tissue sarcomas.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 418, doi. 10.3872/j.issn.1007-385x.2025.04.011
- By:
- Publication type:
- Article
6
Construction and functional study of CD19 CAR-T cells that secrete IL-2 locally.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 356, doi. 10.3872/j.issn.1007-385x.2025.04.002
- By:
- Publication type:
- Article
7
Research progress on bridging therapy for CAR-T cell therapy in multiple myeloma.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 442, doi. 10.3872/j.issn.1007-385x.2025.04.015
- Publication type:
- Article
8
Current situation and challenges of tumor biotherapy based on alternative splicing.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 347, doi. 10.3872/j.issn.1007-385x.2025.04.001
- By:
- Publication type:
- Article
9
Homeobox protein C4 regulates the proliferation, migration and invasion of gastric cancer cells by integrin β1.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 364, doi. 10.3872/j.issn.1007-385x.2025.04.003
- By:
- Publication type:
- Article
10
The intervention of Jianpifuwei granule on mucosal injury of precancerous lesion of gastric cancer via the IL-6/JAK/STAT3 axis and its mechanisms.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 392, doi. 10.3872/j.issn.1007-385x.2025.04.007
- By:
- Publication type:
- Article
11
Predictive value of prognostic nutritional index for treatment efficacy and prognosis in locally advanced esophageal squamous cell carcinoma patients treated with chemotherapy combined with immune sequential radiotherapy.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 405, doi. 10.3872/j.issn.1007-385x.2025.04.009
- By:
- Publication type:
- Article
12
The effects of lncRNA EBLN3P on the proliferation, migration and epithelialmesenchymal transition (EMT) of thyroid cancer B-CPAP cells by regulating the miR-369-3p/CCND1 axis.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 398, doi. 10.3872/j.issn.1007-385x.2025.04.008
- By:
- Publication type:
- Article
13
Expression of KCNN4 in pancreatic cancer tissues, its correlation with prognosis, and impact on pancreatic cancer cell proliferation.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 371, doi. 10.3872/j.issn.1007-385x.2025.04.004
- By:
- Publication type:
- Article
14
DC-CIK cell as an adjuvant to cetuximab combined with CAPEOX chemotherapy regimen for the treatment of 52 cases of advanced colorectal cancer.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 413, doi. 10.3872/j.issn.1007-385x.2025.04.010
- By:
- Publication type:
- Article
15
CircPUM1 regulates malignant biological behaviors of endometrial cancer Ishikawa cells through the miR-337-3p/NPM1 axis.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 378, doi. 10.3872/j.issn.1007-385x.2025.04.005
- By:
- Publication type:
- Article